Cardiovascular Diseases - Drug therapy
Research News and Information

Sunday, November 22, 2009

Nebivolol: the somewhat-different beta-adrenergic receptor blocker.

11 Oct 2009 Although its clinical use in Europe dates almost 10 years, nebivolol is a beta-blocker that has been only recently introduced in the U.S. market. Like carvedilol, nebivolol belongs to the third generation of beta-blockers, which possess direct ... Read more...

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

29 Sep 2009 The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation, antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These endogenous lipid mediators are broken down into diols by soluble epoxide ... Read more...

Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

19 Sep 2009 BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers reduce left ventricular hypertrophy (LVH). The effect of these drugs on LVH in high-risk patients without heart failure is unknown. METHODS AND RESULTS: In ... Read more...

Latest indexed articles for 'Cardiovascular Diseases - Drug therapy'

These are the very latest articles for this heading:

• Periodontitis, atherosclerotic cardiovascular disease and vitamin D. 13 Oct 2009
• Nebivolol: the somewhat-different beta-adrenergic receptor blocker. 11 Oct 2009
• Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. 29 Sep 2009
• The healthy adherer effect. 26 Sep 2009
• Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. 19 Sep 2009
• Pharmacogenetics in cardiovascular antithrombotic therapy. 13 Sep 2009
• Lessons learned from the ONTARGET and TRANSCEND trials. 30 Aug 2009
• Cognitive decline after invasive intervention in cardiovascular disease: is it drug related? 30 Aug 2009
• [Cardiology in the aged, the state of positions and perspectives] 30 Aug 2009
• Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy. 30 Aug 2009
• How to improve cardiovascular diseases prevention in Europe? 30 Aug 2009
• Preinjury statin use is associated with a higher risk of multiple organ failure after injury: a propensity score adjusted analysis. 30 Aug 2009
• Is there a heart rate paradox--demystification of the myths? 30 Aug 2009
• [What future for cardiovascular prevention trials?] 24 Aug 2009
• Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease. 23 Aug 2009
• Cardiovascular disease gets personal. 18 Aug 2009
• Calcium channel blocker toxicity. 30 Jul 2009
• The painful lesson of analgesic drugs: never underestimate the complexity of biological systems. 30 Jul 2009
• Proteinuria: Is the ONTARGET renal substudy actually off target? 30 Jul 2009
• The president's page: target response or target dose. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Cardiovascular Diseases'

Definition: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Descriptor UI: D002318

Alternative terms: Cardiovascular Diseases; Cardiovascular Disease; Disease, Cardiovascular; Diseases, Cardiovascular;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C14;

Technical Notes: general, prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DF: CARDIOVASC DIS